89 related articles for article (PubMed ID: 30447937)
1. A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.
Faiz Z; Dijksterhuis WPM; Burgerhof JGM; Muijs CT; Mul VEM; Wijnhoven BPL; Smit JK; Plukker JTM
Eur J Surg Oncol; 2019 Jun; 45(6):931-940. PubMed ID: 30447937
[TBL] [Abstract][Full Text] [Related]
2. Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Chang X; Deng L; Ni W; Li C; Han W; Gao LR; Wang S; Zhou Z; Chen D; Feng Q; Liang J; Bi N; Lv J; Gao S; Mao Y; Xue Q; Xiao Z
BMC Cancer; 2020 Sep; 20(1):877. PubMed ID: 32928136
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy.
Honing J; Koch AD; Siersema PD; Spaander M
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101885. PubMed ID: 38522883
[TBL] [Abstract][Full Text] [Related]
4. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
Yagi K; Toriumi T; Aikou S; Yamashita H; Seto Y
Ann Gastroenterol Surg; 2021 Jul; 5(4):436-445. PubMed ID: 34337292
[TBL] [Abstract][Full Text] [Related]
5. Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study.
van der Zijden CJ; Bouwman A; Mostert B; Nuyttens JJME; van der Sluis PC; Spaander MCW; Mens JWM; Homs MYV; van Doorn L; Wijnhoven BPL; Lagarde SM
Dis Esophagus; 2024 Jun; ():. PubMed ID: 38836354
[TBL] [Abstract][Full Text] [Related]
6. Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case.
Nagaki Y; Sato Y; Motoyama S; Yoshino K; Sasaki T; Wakita A; Imai K; Saito H; Minamiya Y
Int J Surg Case Rep; 2015; 8C():76-80. PubMed ID: 25644553
[TBL] [Abstract][Full Text] [Related]
7. Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer.
Yano T; Hayashi Y; Ishihara R; Iijima K; Iwakiri K; Uesato M; Oyama T; Katada C; Kawada K; Kushima R; Tateishi Y; Fujii S; Manabe N; Minami H; Kawakubo H; Tsubosa Y; Yamamoto S; Kadota T; Minashi K; Takeuchi H; Doki Y; Muto M
Esophagus; 2024 Apr; 21(2):85-94. PubMed ID: 38353829
[TBL] [Abstract][Full Text] [Related]
8. Waiting to Operate: The Risk of Salvage Esophagectomy.
Boerner T; Harrington C; Tan KS; Adusumilli PS; Bains MS; Bott MJ; Downey RJ; Huang J; Ilson DH; Isbell JM; Janjigian YY; Park BJ; Rocco G; Rusch VW; Sihag S; Wu AJ; Jones DR; Molena D
Ann Surg; 2023 May; 277(5):781-788. PubMed ID: 36727949
[TBL] [Abstract][Full Text] [Related]
9. Treatment of local recurrence of esophageal cancer following Ivor-Lewis esophagectomy-Experiences of a high-volume center.
Knipper K; Krey T; Lyu SI; Jung JO; Wirsik NM; Fuchs HF; Schröder W; Schlößer HA; Popp FC; Quaas A; Bruns CJ; Schmidt T
World J Surg; 2024 Jun; 48(6):1414-1423. PubMed ID: 38554145
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation.
Triantafyllou T; Wijnhoven B
Ann Gastroenterol Surg; 2020 Jul; 4(4):352-359. PubMed ID: 32724878
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy.
Kanekiyo S; Takeda S; Iida M; Nishiyama M; Kitahara M; Shindo Y; Tokumitsu Y; Tomochika S; Tsunedomi R; Suzuki N; Abe T; Yoshino S; Hazama S; Ueno T; Nagano H
Nutrition; 2019 Mar; 59():96-102. PubMed ID: 30468936
[TBL] [Abstract][Full Text] [Related]
12. Ivor Lewis minimally invasive esophagectomy for esophageal cancer: An excellent operation that improves with experience.
White A; Kucukak S; Lee DN; Mazzola E; Zhang Y; Swanson SJ
J Thorac Cardiovasc Surg; 2019 Feb; 157(2):783-789. PubMed ID: 30459111
[TBL] [Abstract][Full Text] [Related]
13. Role of surgery in multidisciplinary treatment strategies for locally advanced esophageal squamous cell carcinoma.
Saeki H; Sohda M; Sakai M; Sano A; Shirabe K
Ann Gastroenterol Surg; 2020 Sep; 4(5):490-497. PubMed ID: 33005843
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus.
Münch S; Pigorsch SU; Devečka M; Dapper H; Feith M; Friess H; Weichert W; Jesinghaus M; Braren R; Combs SE; Habermehl D
Radiat Oncol; 2019 Apr; 14(1):66. PubMed ID: 30992022
[TBL] [Abstract][Full Text] [Related]
15. [Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and resection for squamous cell carcinoma of the esophagus].
Schrempf M; Anthuber M
Chirurg; 2019 Mar; 90(3):239. PubMed ID: 30610259
[No Abstract] [Full Text] [Related]
16. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
17. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Porschen R; Fischbach W; Gockel I; Hollerbach S; Hölscher A; Jansen PL; Miehlke S; Pech O; Stahl M; Vanhoefer U; Ebert MPA
United European Gastroenterol J; 2024 Apr; 12(3):399-411. PubMed ID: 38284661
[TBL] [Abstract][Full Text] [Related]
18. Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer.
Pai CP; Chien LI; Huang CS; Hsu HS; Hsu PK
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001681
[TBL] [Abstract][Full Text] [Related]
19. The evolving landscape of thoracic surgical oncology.
Kim AW; Jaklitsch MT
J Surg Oncol; 2023 Feb; 127(2):217-220. PubMed ID: 36630095
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.
Pape M; Vissers PAJ; Bertwistle D; McDonald L; Beerepoot LV; van Berge Henegouwen MI; Lagarde SM; Mook S; Mohammad NH; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Br J Surg; 2022 Nov; 109(12):1264-1273. PubMed ID: 35998093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
